Cargando…
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries
Primaquine is the only available antimalarial drug that kills dormant liver stages of Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse (‘radical cure’). It is also the only generally available antimalarial that rapidly sterilises mature P. falciparum gametocytes. R...
Autores principales: | Recht, Judith, Ashley, Elizabeth A., White, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908060/ https://www.ncbi.nlm.nih.gov/pubmed/29672516 http://dx.doi.org/10.1371/journal.pntd.0006230 |
Ejemplares similares
-
Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia
por: Valencia, Sócrates Herrera, et al.
Publicado: (2016) -
Nitrofurantoin and glucose-6-phosphate dehydrogenase deficiency: a safety review
por: Recht, Judith, et al.
Publicado: (2022) -
Erratum to: Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia
por: Valencia, Sócrates Herrera, et al.
Publicado: (2016) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023) -
Primaquine: the risks and the benefits
por: Ashley, Elizabeth A, et al.
Publicado: (2014)